"/> Novus Biologicals™ Peptide bloquant d’anticorps PD… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps PDCD4

Réf. : BL-RE-053579Réf. fabricant : 18287335 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
27250
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76738. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 19 amino acids near the carboxy terminus of human PDCD4.

Points forts

Source

Synthetic

(Accession #: NP_663314) The PDCD4 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-053579
Réf. fabricant18287335
Gene ID (Entrez)27250
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76738. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneH731nuclear antigen H731, MGC33046, MGC33047, Neoplastic transformation inhibitor protein, Nuclear antigen H731-like, programmed cell death 4 (neoplastic transformation inhibitor), programmed cell death protein 4, Protein 197/15 A
Symbole de gène(s)PDCD4
Type de produitPDCD4
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne19 amino acids near the carboxy terminus of human PDCD4
Une question, une configuration particulière ?
Contactez-nous pour un devis.